BioVersys AG | WebDisclosure

Basculer en Français

9479	Companies
185504	Keywords
117879	Articles
99354	Press releases

Home
Companies
BioVersys AG

PRESS RELEASE

published on 03/10/2025 at 07:00, 8 months 26 days ago

Bioversys announces partial exercise of over-allotment option
BioVersys announces partial exercise of over-allotment option following successful IPO on the SIX Swiss Exchange, raising total gross proceeds of CHF76.7 million

Biopharmaceutical Company IPO Over-allotment Option BioVersys Multidrug-resistant Bacteria
BRIEF

published on 02/11/2025 at 07:05, 9 months 22 days ago

BioVersys fait progresser le programme BV500 NTM avec le soutien du CF AMR Syndicate

Fibrose Kystique BioVersys SA Programme NTM Assistance LifeArc Chimie De L'ansamycine
BRIEF

published on 02/11/2025 at 07:05, 9 months 22 days ago

BioVersys Advances BV500 NTM Program with CF AMR Syndicate Support

Cystic Fibrosis BioVersys AG NTM Program LifeArc Support Ansamycin Chemistry
PRESS RELEASE

published on 02/11/2025 at 07:00, 9 months 22 days ago

BIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE
BioVersys advances BV500 NTM program with continued support from CF AMR Syndicate, developing therapies for NTM lung disease in CF patients. Company focuses on antibacterial products against MDR bacteria

BioVersys BV500 NTM Program CF AMR Syndicate NTM Lung Disease MDR Bacteria
BRIEF

published on 02/06/2025 at 07:05, 9 months 27 days ago

BioVersys finalise avec succès son introduction en bourse à 36 CHF par action

Capitalisation Boursière Introduction En Bourse Bourse Suisse SIX BioVersys SA Médicaments Antibactériens
BRIEF

published on 02/06/2025 at 07:05, 9 months 27 days ago

BioVersys Successfully Completes IPO at CHF 36 per Share

IPO Market Capitalization SIX Swiss Exchange BioVersys AG Antibacterial Drugs
PRESS RELEASE

published on 02/06/2025 at 07:00, 9 months 27 days ago

BIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW, FEBRUARY 07, 2025
BioVersys successfully completes its IPO at CHF 36 per share, listing on SIX Swiss Exchange on February 07, 2025. The biopharmaceutical company focuses on antibacterial products against multidrug-resistant bacteria

IPO SIX Swiss Exchange Antibacterial Products BioVersys CHF 36
BRIEF

published on 01/29/2025 at 07:05, 10 months 7 days ago

BioVersys AG lance son introduction en bourse à la SIX Swiss Exchange

Offre D'actions Bourse Suisse SIX Introduction En Bourse De BioVersys Biopharma En Phase Clinique Produits Antibactériens
BRIEF

published on 01/29/2025 at 07:05, 10 months 7 days ago

BioVersys AG Launches IPO on SIX Swiss Exchange

SIX Swiss Exchange Share Offering BioVersys IPO Clinical Stage Biopharma Antibacterial Products
PRESS RELEASE

published on 01/29/2025 at 07:00, 10 months 7 days ago

BIOVERSYS LAUNCHES IPO ON THE SIX SWISS EXCHANGE AND SETS IPO PRICE AT CHF 36.00 PER SHARE
BioVersys launches IPO on the SIX Swiss Exchange with an IPO price set at CHF 36.00 per share. Offering expected to raise approximately CHF 80 million in gross proceeds including over-allotment option

IPO SIX Swiss Exchange Offering BioVersys CHF 36.00

Accesswire

Published on 12/05/2025 at 17:15, 15 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 30 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 30 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 45 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 45 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:00, 30 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 5 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 20 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 30 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 30 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 17:18, 12 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 12 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 20 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 20 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 32 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE